Related Experiment Video
Updated: Mar 23, 2026

Mass Cytometry Analysis of Systemic and Local Immune Responses in Hepatocellular Carcinoma
Published on: April 25, 2025
Cellular immune function and liver damage in post-hepatitic cirrhosis
1Zhi-Jie Feng, Ran-Ming Niu, Xi-Ling Ren, Xi-Xian Yao, Department of Internal Medicine, Second Affiliated Hospital, Hebei Medical University, Shijiazhuang 050000, Hebei Province, China.
Cellular immune function is impaired in patients with post-hepatitic cirrhosis (PHC). This immune dysfunction correlates with the severity of liver damage, as indicated by Child-Pugh classification.
Area of Science:
- Immunology
- Hepatology
- Cellular Biology
Background:
- Post-hepatitic cirrhosis (PHC) is a significant cause of liver damage.
- Cellular immune function plays a crucial role in managing liver disease progression.
- Understanding immune status in PHC is vital for assessing disease severity.
Purpose of the Study:
- To investigate cellular immune function in patients with PHC.
- To determine the relationship between immune function and the degree of liver damage in PHC patients.
Main Methods:
- Studied 51 PHC patients (Child-Pugh A, B, C) and 22 healthy controls.
- Isolated peripheral blood mononuclear cells.
- Assessed lymphocyte transformation (LT), IL-2 activity, and NK cell activity using (3)H-TdR incorporation.
Main Results:
- PHC patients showed significantly decreased LT stimulation index, IL-2 activity, and NK cell activity compared to controls.
- Immune function defects were closely related to Child-Pugh classification.
- Immune function was significantly lower in Child-Pugh class C than B and A, and in B than A.
Conclusions:
- Patients with PHC exhibit defective cellular immune functions.
- The degree of immune dysfunction in PHC is directly associated with the severity of liver damage.
More Related Videos
Related Concept Videos
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Liver Physiology
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
Hepatitis
Cell-mediated Immune Responses

